Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Spyre Therapeutics, Inc.

Clinical trials sponsored by Spyre Therapeutics, Inc., explained in plain language.

Spyre Therapeutics, Inc. SYRE NASDAQ

A biotechnology company developing antibody therapies for inflammatory bowel disease.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 4 Completed 1

New drug SPY001-001 tested in healthy people for first time

Knowledge-focused Completed

This early-phase trial tested the safety and tolerability of a new drug called SPY001-001 in 96 healthy volunteers. Participants received either the drug or a placebo, and researchers monitored side effects and how the drug moves through the body. Since this is a first-in-human s…

Phase: PHASE1 • Sponsor: Spyre Therapeutics, Inc. • Aim: Knowledge-focused

Last updated Jun 27, 2026 11:04 UTC